Success Metrics

Clinical Success Rate
100.0%

Based on 12 completed trials

Completion Rate
100%(12/12)
Active Trials
0(0%)
Results Posted
8%(1 trials)

Phase Distribution

Ph phase_1
7
50%
Ph phase_2
7
50%

Phase Distribution

7

Early Stage

7

Mid Stage

0

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
7(50.0%)
Phase 2Efficacy & side effects
7(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

85.7%

12 of 14 finished

Non-Completion Rate

14.3%

2 ended early

Currently Active

0

trials recruiting

Total Trials

14

all time

Status Distribution
Completed(12)
Terminated(2)

Detailed Status

Completed12
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
14
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 17 (50.0%)
Phase 27 (50.0%)

Trials by Status

completed1286%
withdrawn214%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT00383188Phase 2

An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid Arthritis

Completed
NCT00620685Phase 2

A Study To Evaluate The Safety And Pharmacokinetic Profile Of A P38 Inhibitor (PH-797804) In Subjects With Rheumatoid Arthritis Who Are Also Taking Methotrexate

Completed
NCT00559910Phase 2

A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD).

Completed
NCT00827515Phase 1

Relative Bioavailability and Food Effect Study

Withdrawn
NCT01543919Phase 2

Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide

Completed
NCT01102660Phase 2

Clinical Trial to Examine the Pain Relief of PH-797804 Alone Or With Naproxen in Subjects With Osteoarthritis of the Knee

Completed
NCT02084485Phase 1

PH-797804 LPS Study in Healthy Volunteers

Completed
NCT01924650Phase 1

A Pharmacokinetic Study of Three Different Particle Sizes of PH-797804

Withdrawn
NCT01862887Phase 1

A Study to Investigate the Effect of PH-797804 on QTc Interval

Completed
NCT01321463Phase 2

Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) Taking Salmeterol Xinafoate/Fluticasone Propionate Combination

Completed
NCT01589614Phase 1

A Study To Investigate The Effect Of Erythromycin On The Pharmacokinetics Of PH-797804

Completed
NCT01479647Phase 1

A Study To Investigate The Effect Of Food On The Pharmacokinetics Of PH-797804

Completed
NCT01314885Phase 1

Single Dose Lipopolysaccharide (LPS) Study In Healthy Volunteers

Completed
NCT00614705Phase 2

PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic Neuralgia

Completed

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14